1. Home
  2. SNY vs COF Comparison

SNY vs COF Comparison

Compare SNY & COF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNY
  • COF
  • Stock Information
  • Founded
  • SNY 1994
  • COF 1988
  • Country
  • SNY France
  • COF United States
  • Employees
  • SNY N/A
  • COF N/A
  • Industry
  • SNY Biotechnology: Pharmaceutical Preparations
  • COF Major Banks
  • Sector
  • SNY Health Care
  • COF Finance
  • Exchange
  • SNY Nasdaq
  • COF Nasdaq
  • Market Cap
  • SNY 116.5B
  • COF 139.5B
  • IPO Year
  • SNY N/A
  • COF 1994
  • Fundamental
  • Price
  • SNY $48.32
  • COF $218.22
  • Analyst Decision
  • SNY Buy
  • COF Buy
  • Analyst Count
  • SNY 2
  • COF 15
  • Target Price
  • SNY $62.50
  • COF $221.40
  • AVG Volume (30 Days)
  • SNY 2.0M
  • COF 3.5M
  • Earning Date
  • SNY 07-31-2025
  • COF 07-22-2025
  • Dividend Yield
  • SNY 3.31%
  • COF 1.10%
  • EPS Growth
  • SNY 39.56
  • COF N/A
  • EPS
  • SNY 5.45
  • COF 11.91
  • Revenue
  • SNY $48,817,552,946.00
  • COF $28,308,000,000.00
  • Revenue This Year
  • SNY $3.39
  • COF $94.17
  • Revenue Next Year
  • SNY $7.05
  • COF $18.66
  • P/E Ratio
  • SNY $8.86
  • COF $18.29
  • Revenue Growth
  • SNY N/A
  • COF 4.95
  • 52 Week Low
  • SNY $45.80
  • COF $128.23
  • 52 Week High
  • SNY $60.12
  • COF $221.95
  • Technical
  • Relative Strength Index (RSI)
  • SNY 45.01
  • COF 62.96
  • Support Level
  • SNY $47.87
  • COF $213.13
  • Resistance Level
  • SNY $48.80
  • COF $218.86
  • Average True Range (ATR)
  • SNY 0.58
  • COF 3.80
  • MACD
  • SNY 0.10
  • COF -0.67
  • Stochastic Oscillator
  • SNY 28.85
  • COF 64.51

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in vaccines, immunology, oncology, cardiovascular disease, diabetes, and over-the-counter treatments. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing about 30% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

About COF Capital One Financial Corporation

Capital One is a diversified financial services holding company headquartered in McLean, Virginia. Originally a spinoff of Signet Financial's credit card division in 1994, the company is now primarily involved in credit card lending, auto loans, and commercial lending. Following the acquisition of Discover in 2025, the firm also has a modest personal loan business, though credit card lending still provides the majority of the bank's revenue.

Share on Social Networks: